Revance Therapeutics, Inc. $2,328,148 Glaukos Corp $4,075,634 Si-Bone, Inc. $0 Revance Therapeutics, Inc. $2,328,148 Glaukos Corp $4,075,634 Si-Bone, Inc. $0